178 related articles for article (PubMed ID: 22180778)
21. Loss of BMI-1 dampens migration and EMT of colorectal cancer in inflammatory microenvironment through TLR4/MD-2/MyD88-mediated NF-κB signaling.
Ye K; Chen QW; Sun YF; Lin JA; Xu JH
J Cell Biochem; 2018 Feb; 119(2):1922-1930. PubMed ID: 28815730
[TBL] [Abstract][Full Text] [Related]
22. Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients.
Katsura M; Shoji F; Okamoto T; Shimamatsu S; Hirai F; Toyokawa G; Morodomi Y; Tagawa T; Oda Y; Maehara Y
Cancer Sci; 2018 Jan; 109(1):154-165. PubMed ID: 29032612
[TBL] [Abstract][Full Text] [Related]
23. sTLR4/MD-2 complex inhibits colorectal cancer in vitro and in vivo by targeting LPS.
Zou Y; Qin F; Chen J; Meng J; Wei L; Wu C; Zhang Q; Wei D; Chen X; Wu H; Chen X; Dai S
Oncotarget; 2016 Aug; 7(32):52032-52044. PubMed ID: 27409669
[TBL] [Abstract][Full Text] [Related]
24. Close correlation between CXCR4 and VEGF expression and frequent CXCR7 expression in rhabdomyosarcoma.
Miyoshi K; Kohashi K; Fushimi F; Yamamoto H; Kishimoto J; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2014 Sep; 45(9):1900-9. PubMed ID: 25086956
[TBL] [Abstract][Full Text] [Related]
25. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
[TBL] [Abstract][Full Text] [Related]
26. CXCR4 and CXCR7 Mediate TFF3-Induced Cell Migration Independently From the ERK1/2 Signaling Pathway.
Dieckow J; Brandt W; Hattermann K; Schob S; Schulze U; Mentlein R; Ackermann P; Sel S; Paulsen FP
Invest Ophthalmol Vis Sci; 2016 Jan; 57(1):56-65. PubMed ID: 26780310
[TBL] [Abstract][Full Text] [Related]
27. Expression of CXCR7 in colorectal adenoma and adenocarcinoma: Correlation with clinicopathological parameters.
Sherif MF; Ismail IM; Ata SMS
Ann Diagn Pathol; 2020 Dec; 49():151621. PubMed ID: 32949893
[TBL] [Abstract][Full Text] [Related]
28. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
Khare T; Bissonnette M; Khare S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of CXCR7 accelerates tumor growth and metastasis of lung cancer cells.
Liu H; Cheng Q; Xu DS; Wang W; Fang Z; Xue DD; Zheng Y; Chang AH; Lei YJ
Respir Res; 2020 Oct; 21(1):287. PubMed ID: 33129326
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of CXCR4 and CXCR7 with various stem cell markers in paired human primary and recurrent glioblastomas.
Flüh C; Hattermann K; Mehdorn HM; Synowitz M; Held-Feindt J
Int J Oncol; 2016 Apr; 48(4):1408-16. PubMed ID: 26821357
[TBL] [Abstract][Full Text] [Related]
31. CXCR7 mediates TGFβ1-promoted EMT and tumor-initiating features in lung cancer.
Wu YC; Tang SJ; Sun GH; Sun KH
Oncogene; 2016 Apr; 35(16):2123-32. PubMed ID: 26212008
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of CXCR7 inhibits proliferation and invasion of osteosarcoma cells through inhibition of the PI3K/Akt and β-arrestin pathways.
Zhang Y; Yang CQ; Gao Y; Wang C; Zhang CL; Zhou XH
Oncol Rep; 2014 Sep; 32(3):965-72. PubMed ID: 24969680
[TBL] [Abstract][Full Text] [Related]
33. CXC receptor-4 mRNA silencing abrogates CXCL12-induced migration of colorectal cancer cells.
Rubie C; Frick VO; Ghadjar P; Wagner M; Justinger C; Faust SK; Vicinus B; Gräber S; Kollmar O; Schilling MK
J Transl Med; 2011 Feb; 9():22. PubMed ID: 21349176
[TBL] [Abstract][Full Text] [Related]
34. Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer.
Iwakiri S; Mino N; Takahashi T; Sonobe M; Nagai S; Okubo K; Wada H; Date H; Miyahara R
Cancer; 2009 Jun; 115(11):2580-93. PubMed ID: 19309748
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro.
Li JK; Yu L; Shen Y; Zhou LS; Wang YC; Zhang JH
World J Gastroenterol; 2008 Apr; 14(15):2308-13. PubMed ID: 18416455
[TBL] [Abstract][Full Text] [Related]
36. Reduced expression of TLR4 is associated with the metastatic status of human colorectal cancer.
Simiantonaki N; Kurzik-Dumke U; Karyofylli G; Jayasinghe C; Michel-Schmidt R; Kirkpatrick CJ
Int J Mol Med; 2007 Jul; 20(1):21-9. PubMed ID: 17549384
[TBL] [Abstract][Full Text] [Related]
37. [Impact of preoperative drug therapy on the expression of angiogenesis markers in colorectal liver metastases].
Varlamov AV; Pal'tseva EM; Sekacheva MI; Skipenko OG; Fedorov DN
Arkh Patol; 2017; 79(1):36-42. PubMed ID: 28295006
[TBL] [Abstract][Full Text] [Related]
38. Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer.
D'Alterio C; Consales C; Polimeno M; Franco R; Cindolo L; Portella L; Cioffi M; Calemma R; Marra L; Claudio L; Perdonà S; Pignata S; Facchini G; Cartenì G; Longo N; Pucci L; Ottaiano A; Costantini S; Castello G; Scala S
Curr Cancer Drug Targets; 2010 Nov; 10(7):772-81. PubMed ID: 20578990
[TBL] [Abstract][Full Text] [Related]
39. LPS-induced TLR4 signaling in human colorectal cancer cells increases beta1 integrin-mediated cell adhesion and liver metastasis.
Hsu RY; Chan CH; Spicer JD; Rousseau MC; Giannias B; Rousseau S; Ferri LE
Cancer Res; 2011 Mar; 71(5):1989-98. PubMed ID: 21363926
[TBL] [Abstract][Full Text] [Related]
40. Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis.
Hernandez L; Magalhaes MA; Coniglio SJ; Condeelis JS; Segall JE
Breast Cancer Res; 2011; 13(6):R128. PubMed ID: 22152016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
